About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Johnson & Johnson to Pay $2.2 Billion to Settle Allegations of Marketing Irregularities

by Kathy Jones on November 8, 2013 at 9:41 PM
Font : A-A+

 Johnson & Johnson to Pay $2.2 Billion to Settle Allegations of Marketing Irregularities

The US Justice Department has revealed that American drugs company Johnson & Johnson has agreed to pay over $2.2 billion as part of the settlement of allegations over its marketing techniques.

The company had been accused of paying incentives to doctors and pharmacies in order to promote three of its medicines, including anti-psychotic drugs Risperdal and Invega and heart drug Natrecor.

Advertisement

The company has also been accused of promoting drugs for uses not officially allowed.

"They lined their pockets at the expense of the American taxpayers, patients and the private insurance industry. They drove up costs for everyone in the healthcare system and negatively impacted the long term solvency of the central healthcare programmes like Medicare", US Attorney General Eric Holder said.



Source: Medindia
Advertisement

Advertisement
Advertisement

Latest Drug News

How Microrobots Could Help Treat Bladder Diseases?
Microrobots could swirl through a person's blood stream, search for targeted areas to treat for various ailments.
How Can Multivitamin Supplements Slow Cognitive Aging?
Supplementation with multivitamins is an inexpensive way for older adults to slow down memory loss.
 Ivosidenib Approved for Acute Myeloid Leukemia & Advanced Cholangiocarcinoma
Some people with an aggressive blood cancer called acute myeloid leukemia (AML) may soon have a new drug option called Ivosidenib that blocks the activity of IDH1 gene.
Sacubitril/valsartan Unleashes Hope for Heart Failure Patients
In case of cardiac failure where the ejection fraction is greater than 40%, sacubitril/valsartan can prove to be quite beneficial
How Does Antibiotic Treatment for Women With Persistent Acne Work?
Acne treatment with anti-hypertensive drug is a valuable alternative to antibiotics, say physicians.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Johnson & Johnson to Pay $2.2 Billion to Settle Allegations of Marketing Irregularities Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests